Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Intellia Therapeutics Inc Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
January 8, 2021SELL293060.011%ARKK
January 7, 2021SELL1149440.0434%ARKK
November 16, 2020SELL1572470.0477%ARKK
November 13, 2020SELL109760.0033%ARKK
  • 1
  • 5 / page

Key Statistics

🕵🏼Found In🏷Last Price
ARKGARKK$132.37
⚖️Weighting🧢Market Cap
2.45%$9.57b
🏋🏿‍♂️Weight Rank In ARKK🧮Price to Sales
15185.73
🏋️‍♀️Weight Rank Across All Funds🐻Short Percent
175.67
🎫Ark Ownership Percent🌏Country
5.81%🇺🇸United States
Description
Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.
Website
www.intelliatx.com